Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors

Area of Science:

• Cardiovascular Science
• Pharmacology
• Biomedical Engineering

Background:

• Hypertension is a major risk factor for cardiovascular diseases, often exacerbated by increased reactive oxygen species and inflammation.
• Nitric oxide (NO) normally prevents platelet activation, vascular inflammation, and smooth muscle cell migration, but its availability is reduced in hypertension.
• Impaired NO signaling contributes to the pathological processes underlying hypertension.

Purpose of the Study:

• To review the critical role of nitric oxide (NO) in the context of hypertension.
• To highlight the potential of novel nitric oxide-releasing compounds, particularly metal-based drugs, in managing hypertension.
• To discuss the impact of these agents on vascular function.

Main Methods:

• Literature review focusing on nitric oxide's function in cardiovascular health and disease.
• Analysis of studies investigating the therapeutic potential of exogenous nitric oxide administration.
• Examination of research on metal-based compounds as nitric oxide donors.

Main Results:

• Nitric oxide (NO) is essential for maintaining vascular homeostasis by inhibiting platelet and leukocyte activation and modulating inflammation.
• Reduced NO bioavailability during hypertension impairs these protective mechanisms.
• Metal-based nitric oxide donors show significant promise for therapeutic intervention in hypertension.

Conclusions:

• Exogenous administration of nitric oxide represents a viable pharmacological approach for hypertension treatment.
• Metal-containing compounds designed to release NO offer a novel and effective strategy for managing hypertension and related vascular dysfunction.
• Further research into these NO-releasing agents is warranted for cardiovascular disease therapeutics.